Increase of alpha 1-acid glycoprotein after treatment with amitriptyline.

Abstract

British Journal of Clinical PharmacologyVolume 14, Issue 1 p. 102-103 Free Access Increase of alpha 1-acid glycoprotein after treatment with amitriptyline. P. Baumann, P. BaumannSearch for more papers by this authorD. Tinguely, D. TinguelySearch for more papers by this authorJ. Schopf, J. SchopfSearch for more papers by this author P. Baumann, P. BaumannSearch for more papers by this authorD. Tinguely, D. TinguelySearch for more papers by this authorJ. Schopf, J. SchopfSearch for more papers by this author First published: July 1982 https://doi.org/10.1111/j.1365-2125.1982.tb04942.xCitations: 21AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References BAUMANN, P., TINGUELY, D., KOEB, L., SCHÖPF, J. & LE, P.K. (1982). On the relationship between free plasma and saliva amitriptyline and nortriptyline. Int. J. Pharmacopsychiat., (in press). BICKEL, M.H. (1975). Binding of chlorpromazine and imipramine to red cells, albumin, lipoproteins and other blood components. J. Pharm. Pharmac., 27, 733– 738. PIAFSKY, K.M. & BORGA, O. (1977). Plasma protein binding of basic drugs. α1. Importance of a, -acid-glycoprotein for interindividual variation. Clin. Pharmac. Ther., 22, 545– 549. POTTER, W.Z., BERTILSSON, L. & SJÖQVIST, F. (1981). Clinical pharmacokinetics of psychotropic drugs: fundamental and practical aspects. In eds. H.M. Praag, M.H. Lader, O.J. Rafaelsen & E.J. Sachar Handbook of biological psychiatry, vol. VI, pp 71– 134. New York: Marcel Dekker. REES, V.H., FILDES, J.E. & LAURENCE, J.R. (1954). The dye-binding capacity of human plasma determined fluorimetrically and its relation to the determination of plasma albumin. J. clin. Path., 7, 336– 340. ROBINSON, D.S., COOPER, T.B., RAVARIS, C.L., IVES, J.O., NIES, A., BARTLETT, D. & LAMBORN, K.R. (1979). Plasma tricyclic drug levels in amitriptyline-treated depressed patients. Psychopharmacology, 63, 223– 231. ROUTLEDGE, P.A., STARGEL, W.W., FINN, A.L., BARCHOWSKY, A. & SHAND, D.G. (1981). Lignocaine disposition in blood in epilepsy. Br. J. clin. Pharmac., 12, 663– 666. VOLMAT, R., BECHTEL, P., ALLERS, G., VANDEL, B. & VANDEL, S. (1977). Mesure de la concentration plasmatique et effet antidépresseur de l'amitriptyline. Thérapie, 32, 309– 319. ZIEGLER, V.E., CO, B.T., TAYLOR, J.R., CLAYTON, P.J., BIGGS, J.T. (1976). Amitriptyline plasma levels and therapeutic response. Clin. Pharmac. Ther., 19, 759– 801. Citing Literature Volume14, Issue1July 1982Pages 102-103 ReferencesRelatedInformation